Orthopedic Surgeons Say Education Funding Is Casualty Of DOJ Agreements
This article was originally published in The Gray Sheet
Executive Summary
The federal actions against the major orthopedic implant makers last fall have led to a reduction of industry-sponsored medical education, some surgeons say
You may also be interested in...
Surgeon Dorr Keeps Heat On Zimmer, Criticizing The Firm’s Communications
Despite ambitious efforts to overhaul its compliance program, Zimmer's response to an industry-wide Department of Justice settlement has been sub-par in the eyes of orthopedic surgeons and threatens to harm the company in the long term, says prominent surgeon Larry Dorr
Surgeon Dorr Keeps Heat On Zimmer, Criticizing The Firm’s Communications
Despite ambitious efforts to overhaul its compliance program, Zimmer's response to an industry-wide Department of Justice settlement has been sub-par in the eyes of orthopedic surgeons and threatens to harm the company in the long term, says prominent surgeon Larry Dorr
Biomet Looks Abroad For Revenue Growth In Fiscal 2008
Biomet is highlighting growth overseas as a key driver of corporate revenues, and hip and knee reconstruction device sales in particular, reporting 16% top-line expansion for its fiscal fourth quarter (ended May 31)